Description
AOD-9604 5 mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
Not licensed by the MHRA. Not a medicinal product.
Research-grade synthetic peptide fragment supplied as a 5 mg sealed vial for lawful laboratory research in the UK. Not a food, supplement or medical device on this page. Not for diagnostic or therapeutic use. Must not be administered to people or animals. This vial is not human growth hormone.
Identification
| Product name | AOD-9604 |
| Also listed as | hGH fragment 177–191 analogue (Tyr-hGH 177–191) |
| Supplier | Opti-Gen Peptides |
| Contents | 5 mg per vial |
| Sequence (common listing) | Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe |
| CAS | 221231-10-3 |
| Approx. mass | ~1815 Da |
| Class | Synthetic C-terminal GH-fragment analogue |
| Intended use | Laboratory / in-vitro research only |
Quality / storage
Only the lot COA applies. Store as a laboratory chemical under institutional SOP. No preparation or application instructions on this page.
Published research context (not product claims)
AOD-9604 is a modified C-terminal fragment of human growth hormone (region 177–191 with an N-terminal tyrosine). It was developed in academic/industrial programmes associated with Metabolic Pharmaceuticals as a laboratory analogue distinct from intact 191-aa somatropin.
Papers and company-era reports describe in-vitro and animal metabolic-assay work, plus later clinical-development studies that did not produce a UK licensed medicine. Those programmes are historical context only. They are not fat-loss claims for this vial.
AOD-9604 is discussed in WADA materials as a GH-related fragment. That is an anti-doping listing, not a use instruction.
There is no UK marketing authorisation for AOD-9604. It is not a substitute for licensed somatropin.
UK notice
18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.
Reviews
There are no reviews yet.